Correlation Between Allarity Therapeutics and Neximmune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and Neximmune, you can compare the effects of market volatilities on Allarity Therapeutics and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Neximmune.

Diversification Opportunities for Allarity Therapeutics and Neximmune

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Allarity and Neximmune is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Neximmune go up and down completely randomly.

Pair Corralation between Allarity Therapeutics and Neximmune

If you would invest  104.00  in Allarity Therapeutics on December 21, 2024 and sell it today you would lose (8.00) from holding Allarity Therapeutics or give up 7.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Allarity Therapeutics  vs.  Neximmune

 Performance 
       Timeline  
Allarity Therapeutics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Allarity Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak essential indicators, Allarity Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Neximmune 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Allarity Therapeutics and Neximmune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allarity Therapeutics and Neximmune

The main advantage of trading using opposite Allarity Therapeutics and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.
The idea behind Allarity Therapeutics and Neximmune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk